Ron Worton recently retired from the position of CEO and Scientific Director of the Ottawa Health Research Institute, Vice President of Research at the Ottawa Hospital and Professor at the University of Ottawa. His work, primarily on the genetic cause of muscular dystrophy, has resulted in more than 120 publications in leading journals, review articles and book chapters. He has previously served as Geneticist-in-Chief at the Hospital for Sick Children and as Scientific Director of the Stem Cell Network, a Network of Centres of Excellence in Canada. Dr. Worton has served on the boards of many organizations, including the Canadian College of Medical Geneticists, the International Human Genome Organization, and the American Society of Human Genetics, serving as President in 2000. He is currently on the Board of Genome Canada and Chair of the Board of Research Canada. Dr. Worton is the recipient of numerous awards including the Gairdner International Award. He is a Fellow of the Royal Society of Canada and a recipient of the Order of Canada.